Mobile care for persons with opioid use disorder aims to improve HIV prevention and treatment, and reduce opioid overdoses and deaths

A pilot study that hits the road to address two intersecting epidemics-– HIV among people who inject drugs and opioid dependence-– is underway at The University of Texas Health Science Center at Houston (UTHealth）。

研究小组beplay苹果手机能用吗希望更好地了解提供综合的移动医疗服务是否会有助于改善阿片类药物使用障碍药物辅助恢复（MAR）的摄取，从而预防过量服用和死亡，以及抗逆转录病毒疗法（ART）或暴露前预防（在注射阿片类药物的个体中，与已有既有，单数，砖和砂浆服务的人相比。

“在哈里斯县，每年都有大量的新艾滋病毒收购，与阿片类药物使用相关的高死亡率和过量率。”约旦E.湖, MD, MSc, an associate professor of infectious diseases atMcGovern Medical Schoolat UTHealth and the study’s local principal investigator. “Through the work of a multidisciplinary team, we hope to reduce opioid-related overdoses and deaths and acquisition/transmission of HIV in people who inject drugs by providing them with ‘one-stop’ care for treatment, prevention, and recovery.”

In 2017, over70,000美国人死于吸毒过量统计es, and 68% of those deaths were linked to opioid use. People who inject drugs risk both overdose and HIV transmission and acquisition, but often face multiple barriers to care, such as access to treatment and medications for opioid use disorder.

Participants in the intervention group will receive mobile, integrated health care as well as peer navigation from medical and recovery experts for 26 weeks. These services include medication and harm reduction services for opioid use disorder; testing for HIV, viral hepatitis, and other sexually-acquired infections (STI); medications for HIV/STI treatment and prevention; and testing and referrals for other health care needs, including routine vaccinations, viral hepatitis treatment, and other primary care and harm reduction services.

The Houston Emergency Response Opioid Engagement System, or英雄,will direct the peer navigation portion of the intervention. A joint initiative, led by experts at McGovern Medical School and the School of Biomedical Informatics at UTHealth, the HEROES program includes MAR to treat opioid dependence, as well as peer support and counseling from a recovery coach.

“Through this study, we will be able to meet people with opioid use disorder where they are, with health services that are judgment-free and supported by peer navigation,” said詹姆斯·兰加贝尔（James Langabeer）, PhD, EdD, MBA, a coinvestigator on the study and a professor of biomedical informatics, emergency medicine, and public health at UTHealth.

在试用干预的前26周之后，参与者将过渡到其他基于社区的服务，以满足其医疗保健需求。

Eligible participants include adults ages 18 to 60 with opioid use disorder who inject drugs, are at risk of acquiring HIV or are living with HIV, and willing to start opioid use disorder treatment.

Other UTHealth study team members include Roberto Arduino, MD; Karen Vigil, MD; Qiana Allen, NP; Tom Fadial, MD; Shabana Walia, MD, MPH; Maria Martinez, PhD; Jonatan Gioia, MD; Olga Popova, PhD; and Olatunde Oladipupo. The peer coaching team, led by Jessica Yeager, includes Kristina Davis and Stephanie Burns. Study coordinators include Ruda Mohaweche, MD, and Zakir Hossain, MD. Joseph Sanchez will drive the mobile unit and manage security operations.

媒体Inquiries – 713 500 3030